Do we need better hepatitis B vaccines?
作者信息
Gerlich Wolfram H
机构信息
Institute for Medical Virology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, D35292 Giessen, Germany.
出版信息
Indian J Med Res. 2017 Apr;145(4):414-419. doi: 10.4103/ijmr.IJMR_1852_16.
Abstract
摘要
相似文献
1
Do we need better hepatitis B vaccines?我们需要更好的乙肝疫苗吗？
Indian J Med Res. 2017 Apr;145(4):414-419. doi: 10.4103/ijmr.IJMR_1852_16.
2
[Vaccines against viral hepatitis B: results and prospects].[乙型病毒性肝炎疫苗：成果与展望]
Tr Inst Im Pastera. 1992;67:103-15.
3
Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?疫苗设计中的新策略：纳米胶囊能否有助于预防和治疗乙型肝炎？
Nanomedicine (Lond). 2017 Jun;12(11):1205-1207. doi: 10.2217/nnm-2016-0064. Epub 2017 May 18.
4
The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.癌症患儿中含与不含前S2抗原的不同乙肝疫苗的抗体反应比较。
Pediatr Hematol Oncol. 2002 Jun;19(4):227-33. doi: 10.1080/08880010252899389.
5
The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.植物源重组乙肝疫苗的十年进展
Int J Mol Sci. 2016 Oct 13;17(10):1715. doi: 10.3390/ijms17101715.
6
Hepatitis B vaccine recombinant (Janssen/Medeva). Hepagene.重组乙型肝炎疫苗（杨森/梅德瓦）。肝基因。
Drugs R D. 1999 Sep;2(3):201-2. doi: 10.2165/00126839-199902030-00011.
7
Hepatitis B vaccine recombinant (bio-technology general). BioHepB, Sci-B-Vac.重组乙型肝炎疫苗（生物技术通用型）。BioHepB，Sci-B-Vac。
Drugs R D. 1999 Sep;2(3):199-200. doi: 10.2165/00126839-199902030-00010.
8
Nonresponders to hepatitis B vaccine.对乙肝疫苗无反应者。
Postgrad Med. 2000 Mar;107(3):97-8. doi: 10.3810/pgm.2000.03.973.
9
Success of mass vaccination of infants against hepatitis B.婴儿大规模接种乙肝疫苗的成功。
JAMA. 1996 Dec 11;276(22):1802-3. doi: 10.1001/jama.1996.03540220026021.
10
A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).一种新型重组三抗原乙肝疫苗（肝复康）。
Intervirology. 2001;44(2-3):88-97. doi: 10.1159/000050036.
引用本文的文献
1
An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination.隐匿性乙型肝炎感染（OBI）概述，重点关注乙肝疫苗接种。
Heliyon. 2024 Aug 28;10(17):e37097. doi: 10.1016/j.heliyon.2024.e37097. eCollection 2024 Sep 15.
2
Clinical Characteristics of Children With Celiac Disease Not Responding to Hepatitis B Vaccination in India.印度对乙型肝炎疫苗无反应的乳糜泻患儿的临床特征
JPGN Rep. 2021 Jan 13;2(1):e046. doi: 10.1097/PG9.0000000000000046. eCollection 2021 Feb.
3
PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.用于开发联合治疗性/预防性乙型肝炎疫苗的含前S1核心蛋白病毒样颗粒
Microorganisms. 2023 Apr 8;11(4):972. doi: 10.3390/microorganisms11040972.
4
Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1 antigen.乙型肝炎病毒 S/前 S1 抗原诱导有效的细胞和体液免疫应答及产生病毒中和抗体。
Front Immunol. 2022 Jul 22;13:941243. doi: 10.3389/fimmu.2022.941243. eCollection 2022.
5
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.三抗原乙型肝炎疫苗与单抗原乙型肝炎疫苗的免疫原性和安全性：一项 3 期随机临床试验。
JAMA Netw Open. 2021 Oct 1;4(10):e2128652. doi: 10.1001/jamanetworkopen.2021.28652.
6
Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.虾诺达病毒嵌合病毒样颗粒展示乙肝病毒免疫优势区：生物物理特性和细胞因子反应。
Int J Mol Sci. 2021 Feb 15;22(4):1922. doi: 10.3390/ijms22041922.
7
Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso.布基纳法索以E基因型为主的慢性乙型肝炎病毒感染患者的特征
Hepatol Commun. 2020 Sep 15;4(12):1781-1792. doi: 10.1002/hep4.1595. eCollection 2020 Dec.
8
Immunological Analysis of the Hepatitis B Virus "a" Determinant Displayed on Chimeric Virus-Like Particles of Nodavirus Capsid Protein Produced in 9 Cells.对在9细胞中产生的诺达病毒衣壳蛋白嵌合病毒样颗粒上展示的乙型肝炎病毒“a”决定簇的免疫学分析。
Vaccines (Basel). 2020 Jun 4;8(2):275. doi: 10.3390/vaccines8020275.
9
In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations.用于研究乙型肝炎病毒不同基因型/亚型的体外系统：优势和局限性。
Viruses. 2020 Mar 23;12(3):353. doi: 10.3390/v12030353.
10
Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings.乙型肝炎病毒基因、其产物及其抗原特异性命名中的特点：误解的一个潜在来源。
Virus Genes. 2020 Apr;56(2):109-119. doi: 10.1007/s11262-020-01733-9. Epub 2020 Feb 6.
本文引用的文献
1
Management of Chronic Hepatitis B Infection in India.印度慢性乙型肝炎感染的管理
J Assoc Physicians India. 2015 Nov;63(11):43-52.
2
Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.青少年乙型肝炎病毒疫苗加强免疫可降低高危成年人的HBV感染率。
Vaccine. 2017 Feb 15;35(7):1064-1070. doi: 10.1016/j.vaccine.2016.12.062. Epub 2017 Jan 6.
3
[The true story and advantages of the famous Hepatitis B virus core particles: Outlook 2016].[著名乙肝病毒核心颗粒的真实故事及优势：2016年展望]
Mol Biol (Mosk). 2016 Jul-Aug;50(4):558-576. doi: 10.7868/S0026898416040091.
4
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.一种过敏免疫疗法的发展催生了新型乙肝疫苗。
EBioMedicine. 2016 Sep;11:5-6. doi: 10.1016/j.ebiom.2016.07.032. Epub 2016 Jul 27.
5
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担：全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
6
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.替诺福韦预防高病毒载量母亲乙肝母婴传播。
N Engl J Med. 2016 Jun 16;374(24):2324-34. doi: 10.1056/NEJMoa1508660.
7
Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.来自自然康复个体的一系列重组人抗体对前S1-肝细胞相互作用的抑制作用。
Sci Rep. 2016 Feb 18;6:21240. doi: 10.1038/srep21240.
8
Hepatitis B prevalence and treatment needs among Tibetan refugees residing in India.在印度居住的藏裔难民中的乙型肝炎患病率和治疗需求。
J Med Virol. 2016 Aug;88(8):1357-63. doi: 10.1002/jmv.24488. Epub 2016 Feb 8.
9
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.全球慢性乙型肝炎病毒感染患病率的估计：1965 年至 2013 年发表数据的系统评价。
Lancet. 2015 Oct 17;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X. Epub 2015 Jul 28.
10
Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.乙肝感染状况——对安达曼和尼科巴群岛（A&N）乙肝高流行率的原住民部落尼科巴人进行乙肝疫苗接种十年后
Indian J Med Res. 2015 May;141(5):653-61. doi: 10.4103/0971-5916.159573.
Zotero 插件